These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17611620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
    Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, Angata T, Kinjo M, Minami A, Iwasaki N.
    J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.
    Zou W, Zhu T, Craft CS, Broekelmann TJ, Mecham RP, Teitelbaum SL.
    J Cell Sci; 2010 Sep 01; 123(Pt 17):2955-63. PubMed ID: 20720152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.
    Kim HS, Kim DK, Kim AR, Mun SH, Lee SK, Kim JH, Kim YM, Choi WS.
    Cell Signal; 2012 Jun 01; 24(6):1306-14. PubMed ID: 22387224
    [Abstract] [Full Text] [Related]

  • 9. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.
    Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, Chereul E, Langlois JB, Dumontel C, Cavillon G, Confavreux C, Mazzorana M, Vico L, Belin MF, Vivier E, Tomasello E, Jurdic P.
    Am J Pathol; 2005 Jan 01; 166(1):275-86. PubMed ID: 15632019
    [Abstract] [Full Text] [Related]

  • 10. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.
    Mócsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC.
    Proc Natl Acad Sci U S A; 2004 Apr 20; 101(16):6158-63. PubMed ID: 15073337
    [Abstract] [Full Text] [Related]

  • 11. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.
    Humphrey MB, Daws MR, Spusta SC, Niemi EC, Torchia JA, Lanier LL, Seaman WE, Nakamura MC.
    J Bone Miner Res; 2006 Feb 20; 21(2):237-45. PubMed ID: 16418779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 20; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 14. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG, Hofstetter W, Halasy J, Wetterwald A, Felix R.
    Mol Reprod Dev; 1997 Jan 20; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [Abstract] [Full Text] [Related]

  • 15. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y, Takahata M, Mikuni S, Shimizu T, Hamano H, Angata T, Hatakeyama S, Kinjo M, Iwasaki N.
    Bone; 2015 Feb 20; 71():217-26. PubMed ID: 25460183
    [Abstract] [Full Text] [Related]

  • 16. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan 20; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 17. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
    Lee TH, Fevold KL, Muguruma Y, Lottsfeldt JL, Lee MY.
    Exp Hematol; 1994 Jan 20; 22(1):66-73. PubMed ID: 8282061
    [Abstract] [Full Text] [Related]

  • 18. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 20; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 19. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 20; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 20. Osteoclast culture and resorption assays.
    Bradley EW, Oursler MJ.
    Methods Mol Biol; 2008 Sep 20; 455():19-35. PubMed ID: 18463808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.